← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BE PHARMS · Approved 2019-06-26

Drug application

FDA Application #

ANDA212513

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

BE PHARMS

Manufacturer

BE Pharmaceuticals Inc.

First approval

2019-06-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown